Navigation Links
Dengue Virus Gene Replikins Found Conserved and Shared in Current Dengue Strains Back to 1944
Date:8/26/2014

LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Dengue virus strains in Pubmed, has revealed extensive conservation and sharing of specific Replikin structures back to 1944. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Dengue Blocker-Vaccine™ candidate, as it did for the H5N1 influenza vaccine and the Taura Syndrome Shrimp vaccine, both of which have been found to be effective (1,2).

This Dengue vaccine candidate is synthesized in five days and is available freeze-dried to governments and other institutions for testing and use according to the country's regulatory bodies.

For further information: Email 646-320-5910

References:

1. Jackwood et al. Efficacy of a Replikin Peptide Vaccine Against Low-Pathogenicity Avian Influenza H5 Virus. Avian Diseases 53:613-617, 2009.

2. Bogoch S and Bogoch ES. Prediction of specific virus outbreaks made from the increased concentration of a new class of virus genomic peptides, replikins. Nature Precedings doi:10.1038/npre.2011.6279.1



'/>"/>
SOURCE Replikins, Ltd.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
2. Bacterial protein mops up viruses found in contaminated water supplies
3. GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
4. IMDx Obtains CE-Marking for an Automated Molecular Test for Detection and Differentiation of Herpes Simplex Viruses 1 and 2
5. Scientists report successful vaccine developed against deadly Nipah virus
6. Mosquitoes Common in the U.S. Can Transmit Disease-Causing Virus Endemic to Asia
7. JPM-TMT Awards New Contract to Study Administration using Marburg Virus Drug
8. Researchers create laser the size of a virus particle
9. When parasites catch viruses
10. Inovio Pharmaceuticals Cytomegalovirus (CMV) Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study
11. Viruses cooperate or conquer to cause maximum destruction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016  Bayer today announced ... compound Stivarga ® (regorafenib) tablets for the ... has met its primary endpoint of a statistically ... RESORCE, evaluated the efficacy and safety of regorafenib ... after treatment with sorafenib. The safety and tolerability ...
(Date:5/3/2016)... PUNE, India , May 3, 2016 ... Type (DNA Chip (Genomics, Drug Discovery, Gene ... Chips), End user (Academics Institutes, Diagnostics Centers), ... 2020" published by MarketsandMarkets, the market is ... 2020 from USD 7.63 Billion in 2015, ...
(Date:5/3/2016)... ... 2016 , ... Kerafast Inc., developers of an online ... globe, today announced the availability of a Zika virus antibody from Vanderbilt University. ... prevention measures for the Zika virus, the virus’s geographical distribution continues to widen ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... leading fertility clinics and IVF laboratories. A contingency of reproductive endocrinologists, including ... men and women experiencing infertility and to help them build families. , Ovation ...
Breaking Biology Technology:
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):